Publications & working papers

One product, many patents: Imperfect intellectual property rights in the pharmaceutical industry. Selected for presentation at NBER Summer Institute (Innovation)

Strategic entry in regulated markets with Jennifer Kao

Innovation and cross-market spillovers in “big” firms with Matthew Grennan and Mara Lederman

Drug repurposing during the COVID-19 pandemic: Lessons for expediting drug development and access with Wesley Greenblatt and Jennifer Kao, Health Affairs (2023)

Research in progress

Standing on the patents of giants: Concentrated intellectual property rights and cumulative innovation

Competing risks and “missing” medical innovation with Alexander Olssen

Does going public affect pharmaceutical innovation? Evidence from clinical trials with Jennifer Kao

Other writing

Industry, universities, and intellectual property, white paper prepared for the NBER-IFS International Network on the Value of Medical Research